The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study, AIDS, vol.16, issue.10, pp.1363-1370, 2002. ,
DOI : 10.1097/00002030-200207050-00008
Efficacy of Antiretroviral Therapy Programs in Resource???Poor Settings: A Meta???analysis of the Published Literature, Clinical Infectious Diseases, vol.41, issue.2, pp.217-224, 2005. ,
DOI : 10.1086/431199
Generic antiretroviral efficacy in AIDS-associated Kaposi??s sarcoma in sub-Saharan Africa, AIDS, vol.19, issue.4, pp.441-443, 2005. ,
DOI : 10.1097/01.aids.0000161775.36652.85
Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and Facilitators, PLoS Medicine, vol.24, issue.11, p.438, 2006. ,
DOI : 10.1371/journal.pmed.0030438.t007
Efficacy of Interventions in Improving Highly Active Antiretroviral Therapy Adherence and HIV-1 RNA Viral Load, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.43, issue.Supplement 1, pp.23-35, 2006. ,
DOI : 10.1097/01.qai.0000248342.05438.52
No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa, AIDS, vol.19, issue.12, pp.1243-1249, 2005. ,
DOI : 10.1097/01.aids.0000180094.04652.3b
Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.28, issue.5, pp.445-449, 2001. ,
DOI : 10.1097/00042560-200112150-00006
Nonadherence Among HIV-Infected Injecting Drug Users: The Impact of Social Instability, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.31, issue.3, pp.31-149, 2002. ,
DOI : 10.1097/00126334-200212153-00013
Failure to maintain adherence to haart in a cohort of French HIV-positive injecting drug users, International Journal of Behavioral Medicine, vol.35, issue.2, pp.1-14, 2003. ,
DOI : 10.1207/S15327558IJBM1001_01
Factors Associated With Nonadherence to Highly Active Antiretroviral Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.41, issue.4, pp.477-485, 2006. ,
DOI : 10.1097/01.qai.0000186364.27587.0e
Self-Reported Symptoms After Initiation of a Protease Inhibitor in HIV-Infected Patients and Their Impact on Adherence to HAART, HIV Clinical Trials, vol.4, issue.9, pp.38-45, 2001. ,
DOI : 10.1097/00002030-199909100-00022
Psychological variables and adherence to antiretroviral treatment, An Med Interna, vol.17, pp.38-41, 2000. ,
The Dynamic of Adherence to Highly Active Antiretroviral Therapy: Results From the French National APROCO Cohort, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.28, issue.3, pp.232-239, 2001. ,
DOI : 10.1097/00042560-200111010-00005
Options for a Second-Line Antiretroviral Regimen for HIV Type 1-Infected Patients Whose Initial Regimen of a Fixed-Dose Combination of Stavudine, Lamivudine, and Nevirapine Fails, Clinical Infectious Diseases, vol.44, issue.3, pp.447-452, 2007. ,
DOI : 10.1086/510745
Positive Outcomes of HAART at 24 Months in HIV infected Patients in Cambodia AIDS ,
Therapeutic care centered on compliance, Soins, pp.42-45, 2004. ,
Efficacy of an Educational and Counseling Intervention on Adherence to Highly Active Antiretroviral Therapy: French Prospective Controlled Study, HIV Clin Trials, vol.4, pp.121-131, 2003. ,
Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG) AIDS Care, pp.255-266, 2000. ,
Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy, AIDS, vol.15, issue.18, pp.2441-2444, 2001. ,
DOI : 10.1097/00002030-200112070-00012
Development and validation of a self-completed HIV symptom index, Journal of Clinical Epidemiology, vol.54, issue.12, pp.77-90, 2001. ,
DOI : 10.1016/S0895-4356(01)00449-8
Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach, Social Science & Medicine, vol.54, issue.10, pp.1481-1496, 2002. ,
DOI : 10.1016/S0277-9536(01)00125-3
Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users, AIDS, vol.18, issue.9, pp.1321-1325, 2004. ,
DOI : 10.1097/00002030-200406180-00011
Using RT-PCR and bDNA assays to measure non-clade B HIV-1 subtype RNA, Journal of Virological Methods, vol.81, issue.1-2, pp.123-129, 1999. ,
DOI : 10.1016/S0166-0934(99)00057-9
Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting, Journal of Clinical Microbiology, vol.43, issue.6, pp.2709-2717, 2005. ,
DOI : 10.1128/JCM.43.6.2709-2717.2005
Logistic Regression in Rare Events Data Estimating Risk and Rate Levels, Ratios, and Differences in Case-Control Studies, Political analysis, vol.921, issue.26, pp.137-1631409, 2001. ,
Rare Events Logistic Regressio Making the Most of Statistical Analyses, Journal of Statistical Software American Journal of Political Science, vol.844, issue.28, pp.347-361, 2000. ,
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment, The Lancet, vol.367, issue.9519, pp.1335-1342, 2006. ,
DOI : 10.1016/S0140-6736(06)68580-2
Adherence to Antiretroviral Therapy in Sub-Saharan Africa and North America, JAMA, vol.296, issue.6, pp.679-690, 2006. ,
DOI : 10.1001/jama.296.6.679
The relationship of disease severity, health beliefs and medication adherence among HIV patients, AIDS Care, vol.12, issue.4, pp.387-398, 2000. ,
DOI : 10.1080/09540120050123783
Lipodystrophy syndrome associated with antiretroviral therapy in HIV patients: considerations for psychosocial aspects, Revista Latino-Americana de Enfermagem, vol.15, issue.5, pp.1041-1045, 2007. ,
DOI : 10.1590/S0104-11692007000500024
The Care of HIV-Infected Adults in Rural Areas of the United States, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.28, issue.4, pp.385-392, 2001. ,
DOI : 10.1097/00126334-200112010-00013
Barriers to accessing HIV/AIDS care in North Carolina: Rural and urban differences, AIDS Care, vol.133, issue.5, pp.558-565, 2005. ,
DOI : 10.1016/S0277-9536(01)00125-3
Social Stigma Concerns and HIV Medication Adherence, AIDS Patient Care and STDs, vol.20, issue.5, pp.359-368, 2006. ,
DOI : 10.1089/apc.2006.20.359
The Role of HIV Serostatus Disclosure in Antiretroviral Medication Adherence, AIDS and Behavior, vol.90, issue.2, pp.483-493, 2006. ,
DOI : 10.1007/s10461-006-9106-6
Management of HIV-related stigma and adherence to HAART: Evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003), AIDS Care, vol.328, issue.3, pp.254-261, 2006. ,
DOI : 10.1080/09540120500456193
URL : https://hal.archives-ouvertes.fr/inserm-00086761
Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study, Antivir Ther, vol.8, pp.585-594, 2003. ,
A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors, Annals of Internal Medicine, vol.134, issue.10, pp.968-977, 2001. ,
DOI : 10.7326/0003-4819-134-10-200105150-00011
Self-Reported Adherence to Antiretroviral Therapy for HIV-1 Infection and Virologic Treatment Response, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.38, issue.4, pp.445-448, 2005. ,
DOI : 10.1097/01.qai.0000147522.34369.12
The detection of non-adherence by self-administered questionnaires can be optimized by protease inhibitor plasma concentration determination, AIDS, vol.17, issue.7, pp.1096-1099, 2003. ,
DOI : 10.1097/00002030-200305020-00025
???Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy???? A comparison between patients??? self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study, AIDS, vol.15, issue.8, pp.1075-1077, 2001. ,
DOI : 10.1097/00002030-200105250-00024